However, this association was unclear, and correlation with cytogenetic/molecular studies to exclude BCR-ABL1 translocation was recommended. The BCR-ABL1 mutation was negative, which ruled out the possibility of associated CMML. The gene discussed is ABL1; the disease is chronic myelomonocytic leukemia.